Advancing Our Understanding of Treatment-Resistant Schizophrenia (TRS)

Saturday, October 27
7:00 PM - 8:15 PM
Location: Tangerine WF3

Non-CME. Dinner will be served. Seating is limited.
Uncover the latest information, data, and research findings with disease-state or product-specific presentations. Ask questions of key experts and industry representatives and assess the value to your patient care. Seating is limited and available on a first-come, first-served basis. Innovation Theater presentations are not intended or eligible for CME/CE credit.

Moderator:
John Arena
Vice President and General Manager
Psychiatry Franchise
Lundbeck Pharmaceuticals Services, LLC
Deerfield, IL

Faculty
John M. Kane, MD
Professor and Chairman
Department of Psychiatry
The Donald and Barbara Zucker School of Medicine
Hofstra University/Northwell
Hempstead, NY

Jose M. Rubio, MD
Assistant Professor of Psychiatry
The Donald and Barbara Zucker School of Medicine
Hofstra University/Northwell
Hempstead, NY

This presentation is provided by Lundbeck


Assets

Advancing Our Understanding of Treatment-Resistant Schizophrenia (TRS)



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Advancing Our Understanding of Treatment-Resistant Schizophrenia (TRS)